MD Anderson Makes 'Omics a Major Component of New Program to Reduce Cancer Deaths | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Texas MD Anderson Cancer Center on Thursday announced a major initiative that includes genomics components to accelerate scientific discovery into clinical advances in order to reduce the number of cancer deaths.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.